View Item 

Show simple item record

Contrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
dc.contributor.authorGrossman, P. Michael
dc.contributor.authorAli, Syed S.
dc.contributor.authorAronow, Herbert D.
dc.contributor.authorBoros, Michael
dc.contributor.authorNypaver, Timothy J.
dc.contributor.authorSchreiber, Theodore L.
dc.contributor.authorPark, Yeo Jung
dc.contributor.authorHenke, Peter K.
dc.contributor.authorGurm, Hitinder S.
dc.date.accessioned2017-06-16T20:08:08Z
dc.date.available2018-08-07T15:51:22Zen
dc.date.issued2017-06
dc.identifier.citationGrossman, P. Michael; Ali, Syed S.; Aronow, Herbert D.; Boros, Michael; Nypaver, Timothy J.; Schreiber, Theodore L.; Park, Yeo Jung; Henke, Peter K.; Gurm, Hitinder S. (2017). "Contrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium." Journal of Interventional Cardiology 30(3): 274-280.
dc.identifier.issn0896-4327
dc.identifier.issn1540-8183
dc.identifier.urihttps://hdl.handle.net/2027.42/137232
dc.publisherWiley Periodicals, Inc.
dc.subject.otherperipheral vascular interventon
dc.subject.otherperipheral arterial disease
dc.subject.othercontrast‐induced nephropathy
dc.subject.otherquality improvement
dc.titleContrast‐induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137232/1/joic12379.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/137232/2/joic12379_am.pdf
dc.identifier.doi10.1111/joic.12379
dc.identifier.sourceJournal of Interventional Cardiology
dc.identifier.citedreferenceMehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast‐induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44: 1393 – 1399. Epub 2004/10/07.
dc.identifier.citedreferenceTepel M, Aspelin P, Lameire N. Contrast‐induced nephropathy: a clinical and evidence‐based approach. Circulation. 2006; 113: 1799 – 1806. Epub 2006/04/12.
dc.identifier.citedreferenceRihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259 – 2264. Epub 2002/05/16.
dc.identifier.citedreferenceGupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005; 64: 442 – 448. Epub 2005/03/25.
dc.identifier.citedreferenceGurm HS, Lincoff AM, Kleiman NS, et al. Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol. 2004; 94: 30 – 34. Epub 2004/06/29.
dc.identifier.citedreferenceRich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990; 150: 1237 – 1242. Epub 1990/06/01.
dc.identifier.citedreferenceCigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989; 86: 649 – 652. Epub 1989/06/01.
dc.identifier.citedreferenceGruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001; 52: 409 – 416. Epub 2001/04/04.
dc.identifier.citedreferenceLiss P, Persson PB, Hansell P, Lagerqvist B Renal failure in 57925 patients undergoing coronary procedures using iso‐osmolar or low‐osmolar contrast media. Kidney Int. 2006; 70: 1811 – 1817. Epub 2006/09/28.
dc.identifier.citedreferenceFreeman RV, O’Donnell M, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002; 90: 1068 – 1073. Epub 2002/11/09.
dc.identifier.citedreferenceGurm HS, Dixon SR, Smith DE, et al. Renal function‐based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011; 58: 907 – 914. Epub 2011/08/20.
dc.identifier.citedreferenceReed M, Meier P, Tamhane UU, Welch KB, Moscucci M, Gurm HS. The relative renal safety of iodixanol compared with low‐osmolar contrast media: a meta‐analysis of randomized controlled trials. JACC Cardiovasc Interv. 2009; 2: 645 – 654. Epub 2009/07/25.
dc.identifier.citedreferenceBrown JR, Robb JF, Block CA, et al. Does safe dosing of iodinated contrast prevent contrast‐induced acute kidney injury ? Circ Cardiovasc Interv. 2010; 3: 346 – 350. Epub 2010/07/01.
dc.identifier.citedreferenceMukherjee D, Munir K, Hirsch AT, et al. Development of a multicenter peripheral arterial interventional database: the PVD‐QI2. Am Heart J. 2005; 149: 1003 – 1008. Epub 2005/06/25.
dc.identifier.citedreferenceKasapis C, Gurm HS, Chetcuti SJ, et al. Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registry. Circ Cardiovasc Interv. 2010; 3: 593 – 601. Epub 2010/11/11.
dc.identifier.citedreferenceGussenhoven MJ, Ravensbergen J, van Bockel JH, Feuth JD, Aarts JC. Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. J Cardiovasc Surg. 1991; 32: 81 – 86. Epub 1991/01/01.
dc.identifier.citedreferenceMcCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103: 368 – 375. Epub 1997/12/31.
dc.identifier.citedreferenceParfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material‐induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989; 320: 143 – 149. Epub 1989/01/19.
dc.identifier.citedreferencePlaisance BR, Munir K, Share DA, et al. Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registry. JACC Cardiovasc Interv. 2011; 4: 694 – 701. Epub 2011/06/28.
dc.identifier.citedreferenceNikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast‐induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005; 67: 706 – 713. Epub 2005/01/28.
dc.identifier.citedreferenceCaixeta A, Nikolsky E, Mehran R Prevention and treatment of contrast‐associated nephropathy in interventional cardiology. Curr Cardiol Rep. 2009; 11: 377 – 383. Epub 2009/08/28.
dc.identifier.citedreferenceMeier PP, Gurm HS. Is simpler also better? Brief sodium bicarbonate infusion to prevent contrast‐induced nephropathy. Am J Cardiol. 2010; 105: 1042 – 1043. Epub 2010/03/30.
dc.identifier.citedreferenceReed MC, Moscucci M, Smith DE, et al. The relative renal safety of iodixanol and low‐osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Invasive Cardiol. 2010; 22: 467 – 472. Epub 2010/10/15.
dc.identifier.citedreferenceHawkins IF, Cho KJ, Caridi JG. Carbon dioxide in angiography to reduce the risk of contrast‐induced nephropathy. Radiol Clin North Am. 2009; 47: 813 – 825. v–vi. Epub 2009/09/12.
dc.identifier.citedreferenceMadhusudhan KS, Sharma S, Srivastava DN, et al. Comparison of intra‐arterial digital subtraction angiography using carbon dioxide by “home made” delivery system and conventional iodinated contrast media in the evaluation of peripheral arterial occlusive disease of the lower limbs. J Med Imaging Radiat Oncol. 2009; 53: 40 – 49. Epub 2009/05/21.
dc.identifier.citedreferenceSubramanian S, Tumlin J, Bapat B, Zyczynski T. Economic burden of contrast‐induced nephropathy: implications for prevention strategies. J Med Econ. 2007; 10: 119 – 134. Epub 2007/01/01.
dc.identifier.citedreferenceTaliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med. 1986; 104: 501 – 504. Epub 1986/04/01.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
joic12379.pdf
Size:
327.6KB
Format:
PDF
View/Open
Name:
joic12379_am.pdf
Size:
1.220MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.